Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification (INSIGHT)

NCT05338905 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT05338905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05338905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification (INSIGHT)
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 11, 2022
Completion date
December 17, 2027
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma